Why do some drugs preferentially block open sodium channels?
- PMID: 2851053
- DOI: 10.1016/s0022-2828(88)80073-7
Why do some drugs preferentially block open sodium channels?
Abstract
It has been known for some time now that many antiarrhythmics and local anesthetics block sodium channels especially when they are depolarized. Two major phases of channel blocking occur, one "transient" and one "maintained" during the depolarization. Open channel blocking is thought to occur when intracellular forms of drug access the open channel via an aqueous pathway. This early phase of drug access is transient in the sense that opening of channels occurs for only a brief period of time (a few ms) after a depolarizing stimulus. There is also drug access to the receptor during maintained depolarizations, such as during the plateau phase of cardiac action potentials. New results provided by Kodama et al. regarding these two phases of drug blocking, transient and maintained, have prompted the structural analysis presented here. A surprisingly simple size criterion is developed that explains why certain drugs cannot use the pathway that is available during maintained depolarizations.
Similar articles
-
State-dependent trapping of flecainide in the cardiac sodium channel.J Physiol. 2004 Oct 1;560(Pt 1):37-49. doi: 10.1113/jphysiol.2004.065003. Epub 2004 Jul 22. J Physiol. 2004. PMID: 15272045 Free PMC article.
-
[New aspects of the molecular effect of anti-arrhythmia agents].Herz. 1990 Apr;15(2):70-8. Herz. 1990. PMID: 2160907 Review. German.
-
Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.Mol Pharmacol. 1991 Nov;40(5):756-65. Mol Pharmacol. 1991. PMID: 1658608
-
Transcainide causes two modes of open-channel block with different voltage sensitivities in batrachotoxin-activated sodium channels.Biophys J. 1994 Sep;67(3):1028-39. doi: 10.1016/S0006-3495(94)80568-5. Biophys J. 1994. PMID: 7811913 Free PMC article.
-
Antiarrhythmic drugs and the cardiac sodium channel: current models.Clin Chem. 1989 May;35(5):748-54. Clin Chem. 1989. PMID: 2541948 Review.
Cited by
-
Hydrophobic Drug/Toxin Binding Sites in Voltage-Dependent K+ and Na+ Channels.Front Pharmacol. 2020 May 15;11:735. doi: 10.3389/fphar.2020.00735. eCollection 2020. Front Pharmacol. 2020. PMID: 32499709 Free PMC article. Review.
-
Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.Front Pharmacol. 2015 Sep 25;6:210. doi: 10.3389/fphar.2015.00210. eCollection 2015. Front Pharmacol. 2015. PMID: 26441665 Free PMC article.
-
Scavenging nanoparticles: an emerging treatment for local anesthetic toxicity.Reg Anesth Pain Med. 2005 Jul-Aug;30(4):380-4. doi: 10.1016/j.rapm.2005.04.004. Reg Anesth Pain Med. 2005. PMID: 16032590 Free PMC article. No abstract available.
-
Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.J Physiol. 2000 Nov 15;529 Pt 1(Pt 1):93-106. doi: 10.1111/j.1469-7793.2000.00093.x. J Physiol. 2000. PMID: 11080254 Free PMC article.
-
Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.Br J Pharmacol. 1999 Nov;128(6):1165-74. doi: 10.1038/sj.bjp.0702901. Br J Pharmacol. 1999. PMID: 10578128 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
